Capital International Investors Sells 620,843 Shares of Novanta Inc. $NOVT

Capital International Investors reduced its stake in shares of Novanta Inc. (NASDAQ:NOVT) by 82.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,552 shares of the technology company’s stock after selling 620,843 shares during the quarter. Capital International Investors owned 0.38% of Novanta worth $13,475,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Pilgrim Partners Asia Pte Ltd acquired a new position in Novanta during the 3rd quarter worth about $36,000. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in Novanta in the 3rd quarter valued at about $40,000. Harbor Investment Advisory LLC increased its position in Novanta by 47.1% in the 3rd quarter. Harbor Investment Advisory LLC now owns 987 shares of the technology company’s stock valued at $99,000 after acquiring an additional 316 shares in the last quarter. Inceptionr LLC bought a new position in shares of Novanta in the second quarter worth about $213,000. Finally, Blueshift Asset Management LLC bought a new position in shares of Novanta in the second quarter worth about $213,000. Institutional investors and hedge funds own 98.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on NOVT. Robert W. Baird set a $150.00 price target on Novanta in a report on Wednesday, February 25th. Zacks Research raised Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. Finally, Weiss Ratings upgraded shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, January 20th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $150.00.

Insider Buying and Selling

In other news, CFO Robert Buckley sold 1,423 shares of Novanta stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $140.88, for a total value of $200,472.24. Following the completion of the transaction, the chief financial officer owned 93,814 shares of the company’s stock, valued at $13,216,516.32. This trade represents a 1.49% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Matthijs Glastra sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total value of $1,087,800.00. Following the completion of the sale, the chief executive officer owned 57,367 shares in the company, valued at $8,320,509.68. This represents a 11.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 24,346 shares of company stock valued at $3,382,737. Corporate insiders own 1.20% of the company’s stock.

Novanta Stock Down 5.4%

Shares of Novanta stock opened at $119.54 on Friday. Novanta Inc. has a 1 year low of $98.27 and a 1 year high of $149.95. The business has a 50-day moving average of $135.17 and a two-hundred day moving average of $121.16. The company has a market capitalization of $4.27 billion, a P/E ratio of 81.88 and a beta of 1.61. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.69 and a quick ratio of 2.80.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings data on Monday, February 23rd. The technology company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.88 by $0.03. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The business had revenue of $258.35 million for the quarter, compared to analyst estimates of $260.72 million. During the same period last year, the business posted $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. As a group, equities analysts predict that Novanta Inc. will post 3.03 EPS for the current year.

Novanta Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.